Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

24.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biallelic variants in <i>DNAH10</i> are associated with skeletal developmental abnormalities and ciliary dysfunction.

Journal of medical genetics·2026
Same author

Bitter Chinese Herbal Medicine Exerts Pharmacological Effects via TAS2Rs: A Systematic Review from Natural Ligands to Therapeutic Potential.

International journal of molecular sciences·2026
Same author

The novel role of GADD45A in the etiology of autism: modulating neuronal excitability via TET1/R-loop dependent regulation of KCNQ5.

Molecular psychiatry·2026
Same author

Long-Read Sequencing Reveals Cell- and State-Specific Alternative Splicing in 293T and A549 Cell Transcriptomes.

International journal of molecular sciences·2026
Same author

Multilineage-differentiating stress-enduring cells: a powerful tool for tissue damage repair.

Frontiers in cell and developmental biology·2024
Same author

Mechanisms of ferroptosis in nonalcoholic fatty liver disease and therapeutic effects of traditional Chinese medicine: a review.

Frontiers in medicine·2024

Related Experiment Video

Updated: Jul 21, 2025

An Efficient Method for Directed Hepatocyte-Like Cell Induction from Human Embryonic Stem Cells
08:05

An Efficient Method for Directed Hepatocyte-Like Cell Induction from Human Embryonic Stem Cells

Published on: May 6, 2021

3.7K

Pluripotent Stem Cell-Derived Hepatocyte-like Cells: Induction Methods and Applications.

Qiulin Luo1, Nan Wang1, Hanyun Que1

  • 1College of Pharmacy, Southwest Minzu University, Chengdu 610225, China.

International Journal of Molecular Sciences
|July 29, 2023
PubMed
Summary

Induced pluripotent stem cells (iPSCs) offer a promising source for generating hepatocyte-like cells (HLCs) for liver disease treatment. Research focuses on efficient differentiation methods and quality assessment for regenerative medicine applications.

Keywords:
applicationshepatocyte-like cellsinduced pluripotent stem cellsinduction methodsliver disease

More Related Videos

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.3K
Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells
05:43

Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells

Published on: July 27, 2018

8.2K

Related Experiment Videos

Last Updated: Jul 21, 2025

An Efficient Method for Directed Hepatocyte-Like Cell Induction from Human Embryonic Stem Cells
08:05

An Efficient Method for Directed Hepatocyte-Like Cell Induction from Human Embryonic Stem Cells

Published on: May 6, 2021

3.7K
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.3K
Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells
05:43

Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells

Published on: July 27, 2018

8.2K

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Hepatology

Background:

  • Regenerative medicine offers novel therapeutic strategies for end-stage liver diseases.
  • Stem cells, including induced pluripotent stem cells (iPSCs), are crucial for tissue repair.
  • iPSCs present advantages like unlimited proliferation and ethical considerations for generating hepatocytes.

Purpose of the Study:

  • To review current methods for differentiating iPSCs into hepatocyte-like cells (HLCs).
  • To discuss challenges and quality assessment parameters for iPSC-derived HLCs.
  • To explore the use of iPSCs in drug screening and liver disease modeling.

Main Methods:

  • Review of existing literature on iPSC differentiation protocols.
  • Analysis of quality control metrics for iPSC-derived HLCs.
  • Discussion of applications in in vitro drug screening and disease modeling.

Main Results:

  • iPSCs can be differentiated into HLCs with functional and phenotypic similarities to native hepatocytes.
  • Various induction strategies exist, but efficient and accurate differentiation remains a key research area.
  • Established parameters are available for assessing the quality and functionality of differentiated HLCs.

Conclusions:

  • iPSCs represent a reliable cell source for stem cell therapy in liver disease.
  • iPSC-derived HLCs hold potential for personalized liver disease treatment strategies.
  • Further research into efficient differentiation is crucial for clinical translation.